Cargando…

β cell replacement therapy for the cure of diabetes

Islet transplantation is an important option in the treatment of type 1 diabetes. However, a donor shortage and immunosuppressant‐related complications are the current major hurdles of islet transplantation. In this review, we discuss recent updates on islet transplantation to overcome these current...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Joonyub, Yoon, Kun‐Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623521/
https://www.ncbi.nlm.nih.gov/pubmed/35818819
http://dx.doi.org/10.1111/jdi.13884
_version_ 1784822014841716736
author Lee, Joonyub
Yoon, Kun‐Ho
author_facet Lee, Joonyub
Yoon, Kun‐Ho
author_sort Lee, Joonyub
collection PubMed
description Islet transplantation is an important option in the treatment of type 1 diabetes. However, a donor shortage and immunosuppressant‐related complications are the current major hurdles of islet transplantation. In this review, we discuss recent updates on islet transplantation to overcome these current obstacles and we share our perspectives on future β cell replacement therapy.
format Online
Article
Text
id pubmed-9623521
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96235212022-11-02 β cell replacement therapy for the cure of diabetes Lee, Joonyub Yoon, Kun‐Ho J Diabetes Investig Mini Review Islet transplantation is an important option in the treatment of type 1 diabetes. However, a donor shortage and immunosuppressant‐related complications are the current major hurdles of islet transplantation. In this review, we discuss recent updates on islet transplantation to overcome these current obstacles and we share our perspectives on future β cell replacement therapy. John Wiley and Sons Inc. 2022-07-29 2022-11 /pmc/articles/PMC9623521/ /pubmed/35818819 http://dx.doi.org/10.1111/jdi.13884 Text en © 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Mini Review
Lee, Joonyub
Yoon, Kun‐Ho
β cell replacement therapy for the cure of diabetes
title β cell replacement therapy for the cure of diabetes
title_full β cell replacement therapy for the cure of diabetes
title_fullStr β cell replacement therapy for the cure of diabetes
title_full_unstemmed β cell replacement therapy for the cure of diabetes
title_short β cell replacement therapy for the cure of diabetes
title_sort β cell replacement therapy for the cure of diabetes
topic Mini Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623521/
https://www.ncbi.nlm.nih.gov/pubmed/35818819
http://dx.doi.org/10.1111/jdi.13884
work_keys_str_mv AT leejoonyub bcellreplacementtherapyforthecureofdiabetes
AT yoonkunho bcellreplacementtherapyforthecureofdiabetes